Cytokinetics (CYTK) Payables: 2009-2025
Historic Payables for Cytokinetics (CYTK) over the last 16 years, with Sep 2025 value amounting to $22.1 million.
- Cytokinetics' Payables rose 90.69% to $22.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $72.6 million, marking a year-over-year increase of 30.79%. This contributed to the annual value of $20.4 million for FY2024, which is 5.29% down from last year.
- As of Q3 2025, Cytokinetics' Payables stood at $22.1 million, which was up 36.09% from $16.2 million recorded in Q2 2025.
- In the past 5 years, Cytokinetics' Payables registered a high of $25.6 million during Q4 2022, and its lowest value of $7.8 million during Q1 2021.
- Moreover, its 3-year median value for Payables was $13.9 million (2025), whereas its average is $15.6 million.
- As far as peak fluctuations go, Cytokinetics' Payables surged by 411.23% in 2021, and later decreased by 25.29% in 2024.
- Quarterly analysis of 5 years shows Cytokinetics' Payables stood at $21.1 million in 2021, then climbed by 21.45% to $25.6 million in 2022, then declined by 16.02% to $21.5 million in 2023, then declined by 5.29% to $20.4 million in 2024, then spiked by 90.69% to $22.1 million in 2025.
- Its Payables was $22.1 million in Q3 2025, compared to $16.2 million in Q2 2025 and $13.9 million in Q1 2025.